What is it about?
Tuberculosis (TB) is a leading cause of death worldwide. Cholesterol plays an important role in TB infection. Enzymes involved in the cholesterol pathway in M. tuberculosis represent potential drug targets for antitubercular therapy development. This review summarises reported enzyme inhibitors targeting the cholesterol pathway.
Featured Image
Read the Original
This page is a summary of: Cholesterol metabolism: a potential therapeutic target in Mycobacteria, British Journal of Pharmacology, January 2017, Wiley,
DOI: 10.1111/bph.13694.
You can read the full text:
Contributors
Be the first to contribute to this page